TCOV
AMGN icon

Trust Company of Vermont’s Amgen AMGN Stock Holding History

Trust Company of Vermont’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.35M Sell
22,458
-162
-0.7% -$51.4K 0.31% 76
2025
Q3 		$6.38M Buy
22,620
+361
+2% +$105K 0.28% 79
2025
Q2 		$6.21M Sell
22,259
-172
-0.8% -$48.7K 0.29% 79
2025
Q1 		$6.99M Sell
22,431
-814
-4% -$240K 0.35% 73
2024
Q4 		$6.06M Buy
23,245
+35
+0.2% +$10.4K 0.29% 81
2024
Q3 		$7.48M Sell
23,210
-399
-2% -$131K 0.37% 70
2024
Q2 		$7.38M Sell
23,609
-151
-0.6% -$44.4K 0.4% 67
2024
Q1 		$6.76M Buy
23,760
+6,116
+35% +$1.79M 0.38% 71
2023
Q4 		$5.08M Sell
17,644
-6,197
-26% -$1.69M 0.34% 79
2023
Q3 		$6.41M Sell
23,841
-2,682
-10% -$669K 0.43% 63
2023
Q2 		$5.89M Sell
26,523
-3,295
-11% -$765K 0.38% 73
2023
Q1 		$7.21M Sell
29,818
-222
-0.7% -$54.5K 0.5% 64
2022
Q4 		$7.89M Buy
30,040
+383
+1% +$103K 0.58% 48
2022
Q3 		$6.68M Buy
29,657
+1,322
+5% +$320K 0.53% 54
2022
Q2 		$6.89M Sell
28,335
-1,041
-4% -$255K 0.53% 61
2022
Q1 		$7.1M Buy
29,376
+285
+1% +$65.5K 0.48% 70
2021
Q4 		$6.54M Sell
29,091
-824
-3% -$174K 0.41% 75
2021
Q3 		$6.36M Sell
29,915
-942
-3% -$217K 0.45% 71
2021
Q2 		$7.52M Sell
30,857
-72
-0.2% -$17.7K 0.52% 61
2021
Q1 		$7.7M Sell
30,929
-306
-1% -$73K 0.58% 56
2020
Q4 		$7.18M Buy
31,235
+468
+2% +$108K 0.57% 55
2020
Q3 		$7.82M Buy
30,767
+27
+0.1% +$6.69K 0.72% 45
2020
Q2 		$7.25M Sell
30,740
-9,766
-24% -$2.23M 0.72% 46
2020
Q1 		$8.21M Sell
40,506
-192
-0.5% -$41.9K 0.77% 43
2019
Q4 		$9.81M Sell
40,698
-553
-1% -$122K 0.74% 47
2019
Q3 		$7.98M Buy
41,251
+108
+0.3% +$20.7K 0.64% 54
2019
Q2 		$7.58M Buy
41,143
+308
+0.8% +$55.1K 0.63% 55
2019
Q1 		$7.76M Buy
40,835
+538
+1% +$103K 0.67% 54
2018
Q4 		$7.84M Buy
40,297
+99
+0.2% +$19.3K 0.76% 50
2018
Q3 		$8.33M Buy
40,198
+785
+2% +$155K 0.7% 50
2018
Q2 		$7.28M Buy
39,413
+528
+1% +$93.4K 0.65% 51
2018
Q1 		$6.63M Buy
38,885
+996
+3% +$183K 0.63% 54
2017
Q4 		$6.59M Buy
37,889
+1,215
+3% +$215K 0.61% 53
2017
Q3 		$6.84M Buy
36,674
+767
+2% +$136K 0.68% 49
2017
Q2 		$6.18M Buy
35,907
+2,147
+6% +$349K 0.63% 54
2017
Q1 		$5.54M Buy
33,760
+1,614
+5% +$268K 0.6% 56
2016
Q4 		$4.7M Buy
32,146
+2,451
+8% +$369K 0.54% 61
2016
Q3 		$4.95M Buy
29,695
+5,130
+21% +$867K 0.62% 55
2016
Q2 		$3.74M Buy
24,565
+3,740
+18% +$581K 0.5% 71
2016
Q1 		$3.12M Buy
20,825
+1,162
+6% +$173K 0.44% 77
2015
Q4 		$3.19M Buy
19,663
+1,809
+10% +$284K 0.46% 74
2015
Q3 		$2.47M Buy
17,854
+1,250
+8% +$197K 0.38% 87
2015
Q2 		$2.55M Buy
16,604
+207
+1% +$33.2K 0.37% 88
2015
Q1 		$2.62M Buy
16,397
+48
+0.3% +$7.56K 0.38% 83
2014
Q4 		$2.6M Buy
16,349
+460
+3% +$71.7K 0.38% 82
2014
Q3 		$2.23M Buy
15,889
+5,810
+58% +$759K 0.34% 90
2014
Q2 		$1.19M Buy
10,079
+7
+0.1% +$810 0.18% 127
2014
Q1 		$1.24M Sell
10,072
-160
-2% -$19.4K 0.2% 123
2013
Q4 		$1.17M Sell
10,232
-210
-2% -$23.9K 0.2% 121
2013
Q3 		$1.17M Hold
10,442
– – 0.21% 116
2013
Q2 		$1.03M Buy
+10,442
New +$1.08M 0.2% 112

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Trust Company of Vermont's AMGN Position: Q4 2025 in Review

Trust Company of Vermont reduced its Amgen (AMGN) stake by 0.72% in Q4 2025, selling an estimated $51.4K and leaving 22,458 shares worth $7.35M. The position accounts for 0.31% of the portfolio, ranked #76.

Trust Company of Vermont first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $9.81M in Q4 2019. 3,085 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Trust Company of Vermont held 22,458 shares of Amgen worth $7.35M as of Q4 2025.
  • Trust Company of Vermont sold 162 Amgen shares in Q4 2025, an estimated $51.4K.
  • Amgen made up 0.31% of Trust Company of Vermont's portfolio in Q4 2025, its #76 holding.
  • Trust Company of Vermont first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Trust Company of Vermont's Amgen position peaked at $9.81M in Q4 2019.
  • 3,085 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.